Role of inflammation in the pathogenesis of age-related macular degeneration

References

• The Eye Diseases Prevalence Study Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol.122, 564–572 (2004).
   PubMed Web of Science ®Google Scholar
• Congdon N, O’Colmain B, Klaver CC; The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol.122, 477–485 (2004).
   PubMed Web of Science ®Google Scholar
• Augood CA, Vingerling JR, de Jong PTVM et al. Prevalence of age-related maculopathy in older Europeans: The European Eye Study (EurEye). Arch. Ophthalmol.124, 529–535 (2006).
   PubMed Web of Science ®Google Scholar
• Nettleship E. Central areolar choroidal atrophy. Trans. Soc. Ophthalmol. UK4, 165–166 (1884).
   Google Scholar
• Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Arch. Ophthalmol.117, 1329–1345 (1999).
   PubMed Web of Science ®Google Scholar
• Coleman HR, Chan CC, Ferris FL III et al. Age-related macular degeneration. Lancet372, 1835–1845 (2008).
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N. Engl. J. Med.358, 2606–2617 (2008).
   PubMed Web of Science ®Google Scholar
• Klein R. Overview of progress in the eoidemiology of age-related macular degeneration. Ophthalmic Epidemiol.14, 184–187 (2007).
   PubMed Web of Science ®Google Scholar
• Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res.28, 1–18 (2009).
   PubMed Web of Science ®Google Scholar
• Tsoumakidou M, Demedts IK, Brusselle GG et al. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am. J. Respir. Crit. Care Med.177, 1180–1186 (2008).
   PubMed Web of Science ®Google Scholar
• Augustin AJ, Kirchhof J. Inflammation and the pathogenesis of age-related macular degeneration. Expert Opin. Ther. Targets13, 1–11 (2009).
   PubMed Web of Science ®Google Scholar
• Anderson DH, Ozaki S, Nealon M. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol.131, 767–781 (2001).
   PubMed Web of Science ®Google Scholar
• Johnson LV, Ozaki S, Staples MK. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Research70, 441–449 (2000).
   PubMed Web of Science ®Google Scholar
• Feeney-Burns L, Hilderbrand ES, Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest. Ophthalmol. Vis. Sci.25, 195–200 (1984).
   PubMed Web of Science ®Google Scholar
• Bird JC, Marshall J. Retinal pigment detachments in the elderly. Trans. Opthalmol. Soc. UK105, 674–682 (1986).
   PubMedGoogle Scholar
• Hammes HP, Hoerauf H, Alt A et al. Ne(carboxymethyl) lysin and the AGE receptor RAGE co-localize in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.40, 1855–1859 (1999).
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Murata T, Hangai M et al. Advanced glycation end products in age-related macular degeneration. Arch. Ophthalmol.116, 1629–1632 (1998).
   PubMedGoogle Scholar
• Hageman GS, Luthert PJ, Chong NHV. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res.20, 705–732 (2001).
   PubMed Web of Science ®Google Scholar
• Ramrattan RS, van der Schaft TL, Mooy CM. Morphometric analysis of Bruch‘s membrane, the choriocapillaris, and the choroid in aging. Invest. Ophthalmol. Vis. Sci.35, 2857–2864 (1994).
   PubMed Web of Science ®Google Scholar
• Pauleikhoff D, Harper CA, Marshall J et al. Aging changes in Bruch’s membrane. A histochemical and morphologic study. Ophthalmology97, 171–178 (1990).
   PubMed Web of Science ®Google Scholar
• Marmorstein AD, Finnemann SC, Bonilha VL et al. Morphogenesis of the retinal pigment epithelium: toward understanding retinal degenerative diseases. Ann. NY Acad. Sci.857, 1–12 (1998).
   PubMed Web of Science ®Google Scholar
• Crabb JW, Miyagi M, Gu X et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA99, 14682–14687 (2002).
   PubMed Web of Science ®Google Scholar
• Hagemann GS, Mullins RF, Russel SR et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J.13, 477–484 (1999).
   PubMed Web of Science ®Google Scholar
• Johnson LV, Leitner WP, Staples MK et al. Complement activation and inflammatory process in drusen formation and age-related macular degeneration. Exp. Eye Res.73, 887–896 (2001).
   PubMed Web of Science ®Google Scholar
• Mullins RF, Aptsiauri N, Hagemann GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye15, 390–395 (2001).
   PubMed Web of Science ®Google Scholar
• Nozaki M, Raisler BJ, Sakurai E et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl Acad. Sci. USA103, 2328–2333 (2006).
   PubMed Web of Science ®Google Scholar
• Bora PS, Sohn JH, Cruz JM et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol.174, 491–497 (2005).
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. First of two parts. N. Eng. J. Med.344, 1058–1066 (2001).
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. Second of two parts. N. Eng. J. Med.344, 1140–1144 (2001).
   PubMed Web of Science ®Google Scholar
• Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science308(5720), 385–389 (2005).
   PubMed Web of Science ®Google Scholar
• Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science308(5720), 419–421 (2005).
   PubMed Web of Science ®Google Scholar
• Edwards AO, Ritter R 3rd, Abel KJ et al. Complement factor H polymorphism and age-related macular degeneration. Science308(5720), 421–424 (2005).
   PubMed Web of Science ®Google Scholar
• Zareparsi S, Branham KE, Li M et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet.77, 149–153 (2005).
   PubMed Web of Science ®Google Scholar
• Mullins RF, Russell SR, Anderson DH et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis and dense deposit disease. FASEB J.14, 835–846 (2000).
   PubMed Web of Science ®Google Scholar
• Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet.38, 458–462 (2006).
   PubMed Web of Science ®Google Scholar
• Dinu V, Miller PL, Zhao H. Evidence for association between multiple complement pathway genes and AMD. Genet. Epidemiol.31, 224–237 (2007).
   PubMed Web of Science ®Google Scholar
• Ennis S, Jomary C, Mullins R et al. Association between the SERPING1 gene and age-related macular degeneration: a two stage case–control study. Lancet372, 1828–1834 (2008).
   PubMed Web of Science ®Google Scholar
• Mori K, Horie-Inoue K, Kohda M et al. Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J. Hum. Genet.52, 636–641 (2007).
   PubMed Web of Science ®Google Scholar
• Lu F, Hu J, Zhao P et al.HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population. Vision Res.47, 3120–3123 (2007).
   PubMed Web of Science ®Google Scholar
• Leveziel N, Souied EH, Richard F et al.PLEKHA1-LOC387715/ARMS2-HTRA1 polymorphisms and exsudative age-related macular degeneration in the French population. Mol. Vis.13, 2153–2159 (2007).
   PubMed Web of Science ®Google Scholar
• Seddon JM, Francis PJ, George S et al. Association of CFHY402H and LOC387715A69S with progression of age-related macular degeneration. JAMA297, 1793–1800 (2007).
   PubMed Web of Science ®Google Scholar
• Gibbs D, Yang Z, Constantine R et al. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res.48, 685–689 (2008).
   PubMed Web of Science ®Google Scholar
• Tam PO, Ng TK, Liu DT et al.HTRA1 variants in exsudative age-related macular degeneration and interactions with smoking and CFH. Invest. Ophthalmol. Vis. Sci.49, 2357–2365 (2008).
   PubMed Web of Science ®Google Scholar
• Yang Z, Camp NJ, Sun H et al. A variant of the HTRA1 gene increases susceptibilty to age-related macular degeneration. Science314, 992–993 (2006).
   PubMed Web of Science ®Google Scholar
• Kanda A, Chen W, Othman M et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc. Natl Acad. Sci. USA104, 16227–16232 (2007).
   PubMed Web of Science ®Google Scholar
• Canfield AE, Hadfield KD, Rock CF et al.HTRA1: a novel regulator of physiological and pathological matrix mineralization? Biochem. Soc. Trans.35, 669–671 (2007).
   PubMed Web of Science ®Google Scholar
• Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in age-related macular degeneration. Retina27, 269–275 (2007).
   PubMed Web of Science ®Google Scholar
• Rivera A, Fisher SA, Fritsche LG et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet.14, 3227–3236 (2005).
   PubMed Web of Science ®Google Scholar
• Robman L, Mahdi O, McCarty C et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. Am. J. Epidemiol.161, 1013–1019 (2005).
   PubMed Web of Science ®Google Scholar
• Kalayoglu MV, Bula D, Arroyo D et al. Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol.243, 1080–1090 (2005).
   PubMed Web of Science ®Google Scholar
• Baird PN, Robman LD, Richardson AJ et al. Gene–environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. Hum. Mol. Genet.17, 1299–1305 (2008).
   PubMed Web of Science ®Google Scholar
• Thornton J, Edwards R, Mitchell P et al. Smoking and age-related macular degeneration: a review of association. Eye19, 935–944 (2005).
   PubMed Web of Science ®Google Scholar
• Neuner B, Wellmann J, Dasch B et al. Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy. Ann. Epidemiol.17, 615–621 (2007).
   PubMed Web of Science ®Google Scholar
• Wang JJ, Rochtchina E, Smith W et al. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. Am. J. Epidemiol.169(5), 633–641 (2009).
   PubMed Web of Science ®Google Scholar
• Schmidt S, Hauser MA, Scott WK et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet.78, 852–864 (2006).
   PubMed Web of Science ®Google Scholar
• Seddon JM, George S, Rosner B et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin-6, and other cardiovascular biomarkers. Arch. Ophthalmol.123, 774–782 (2005).
   PubMed Web of Science ®Google Scholar
• Vine AK, Stader J, Branham K et al. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology112, 2076–2080 (2005).
   PubMed Web of Science ®Google Scholar
• Kim IK, Ji F, Morrison MA et al. Comprehensive analysis of CRP, CFHY402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol. Vis.14, 1487–1495 (2008).
   PubMed Web of Science ®Google Scholar
• Despriet DD, Klaver CC, Wittemann JC et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA296, 301–309 (2006).
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Christen WG, Kozlowski P et al. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.47, 2336–2340 (2006).
   PubMed Web of Science ®Google Scholar
• Du Clos TW. Function of C-reactive protein. Ann. Med.32, 274–278 (2000).
   PubMed Web of Science ®Google Scholar
• Tuo J, Smith BC, Bojanowski CM et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J.18, 1297–1299 (2004).
   PubMed Web of Science ®Google Scholar
• Combadiere C, Feumi C, Raoul W et al. CX3CR1-dependent subretinal microglia cell accunulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest.117, 2920–2928 (2007).
   PubMed Web of Science ®Google Scholar
• Yang Z, Stratton C, Francis PJ et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N. Engl. J. Med.359, 1456–1463 (2008).
   PubMed Web of Science ®Google Scholar
• Edwards AO, Chen D, Fridley BL et al. Toll-like receptor polymorphisms and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.49, 1652–1659 (2008).
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Ferris F 3rd. Age-related macular degeneration and the immune response: implications for therapy. Am. J. Ophthalmol.144, 618–626 (2007).
   PubMed Web of Science ®Google Scholar
• Dastgheib K, Green WR. Granulomatous reaction to Bruch’s membrane in age-related macular degeneration. Arch. Ophthalmol.112, 813–818 (1994).
   PubMedGoogle Scholar
• Csaky K, Baffi J, Chan CC et al. Clinicopathologic correlation of progressive fibrovascular proliferation associated with occult choroidal neovascularisation in age-related macular degeneration. Arch. Ophthalmol.122, 650–652 (2004).
   PubMedGoogle Scholar
• Espinosa-Heidmann DG, Suner IJ, Hernandez EP et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.44, 3586–3592 (2003).
   PubMed Web of Science ®Google Scholar
• Apte RS, Richter J, Herndon J et al. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med.3(8), e310 (2006).
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol.25, 677–686 (2004).
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE, Ling JX, Wallace TM et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis.8, 119–126 (2002).
   PubMed Web of Science ®Google Scholar
• Langmann T. Microglia activation in retinal degeneration. J. Leukoc. Biol.81, 1345–1313 (2007).
   PubMed Web of Science ®Google Scholar
• McGeer EG, Klegeris A, McGeer PL. Inflammation, the complement system and the diseases of aging. Neurobiol. Aging26S1, S94–S97 (2005).
   Google Scholar
• Das UN. Is angiotensin II an endogenous pro-inflammatory molecule? Med. Sci. Monit.11, 155–162 (2005).
   Web of Science ®Google Scholar
• Beatty S, Koh H, Phil M et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol.45, 115–134 (2000).
   PubMed Web of Science ®Google Scholar
• Gu X, Meer SG, Miyagi M et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem.278, 42027–42035 (2003).
   PubMed Web of Science ®Google Scholar
• Hollyfield JG, Bonilha VL, Rayborn ME et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med.14, 194–198 (2008).
   PubMed Web of Science ®Google Scholar
• Kamei M, Yoneda K, Kume N et al. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.48, 1801–1807 (2007).
   PubMed Web of Science ®Google Scholar